190 results
Page 5 of 10
8-K
EX-99.2
67hxn2i83fxzy
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K
EX-99.1
qkofs umr
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
0l9x i920
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
c7438q q4v7lj
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.1
ng02b0i2u76epuwh pz6
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.2
jjtg5cwmcmqx5cj
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-99.1
0f05xedo2ulm8e4s1wwc
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.3
47y hd7882
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.4
tc0ewzcv
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
qf36e0p3fm6
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
xq9 h73h87r
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
98drx
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-10.1
ndz6a42g
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm